Cochrane Abstracts
Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hydroxyurea (hydroxycarbamide) for Transfusion‐dependent Β‐thalassaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439937/all/Hydroxyurea__hydroxycarbamide__for_transfusion‐dependent_β‐thalassaemia.
Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439937/all/Hydroxyurea__hydroxycarbamide__for_transfusion‐dependent_β‐thalassaemia. Accessed March 26, 2025.
Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439937/all/Hydroxyurea__hydroxycarbamide__for_transfusion‐dependent_β‐thalassaemia
Hydroxyurea (hydroxycarbamide) for Transfusion‐dependent Β‐thalassaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439937/all/Hydroxyurea__hydroxycarbamide__for_transfusion‐dependent_β‐thalassaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia
ID - 439937
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439937/all/Hydroxyurea__hydroxycarbamide__for_transfusion‐dependent_β‐thalassaemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
